Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 306
- Uncategorized
Deutsches Pharmaunternehmen steigt mit dem Kauf von Canopy Growth European Asset in den Cannabisbereich ein
Mit der Übernahme der Canopy Growth-Tochter C³ Group durch das deutsche Unternehmen Dermapharm Holding ist ein weiterer Beleg für das Interesse der Pharmaindustrie am europäischen Cannabis-Markt aufgetaucht.
- Pharmaceutical
German Pharmaceutical Firm Enters Cannabis Space With Purchase Of Canopy Growth European Asset
FURTHER evidence of pharmaceutical interest in the European cannabis space has emerged with German business Dermapharm Holding acquiring Canopy Growth subsidiary C³ Group.
- News
After Securing Cultivation Licence Guernsey-Based 4C Labs Will Open UK Medical Cannabis Tele-Clinics
4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch virtual health clinics in the coming year.
- Press releases
Kanabo’s CBD Based ‘Smoking Cessation” Formula Moves Closer to Full Patent Approval
Kanabo Group Plc (LSE:KNB), a medical cannabis and R&D Company that focuses on the distribution of cannabis-derived products for medical patients and wellness CBD consumers, is pleased to announce that its unique CBD and nicotine formula has advanced from Patent Cooperation Treaty (PCT) phase to National Phase in the US, UK, and EU countries – the…
- CBD Market
Mo’ money, cannabis research, the canna-verse and THC in the EU
Capital raises in cannabis exceed pre-pandemic levels to $10+ billion Cannabis industry capital raises exceeded pre-pandemic levels in 2021, with $10.1 billion raised in the first three quarters of the year, according to New Frontier Data’s new report, Cultivating Capital: Cannabis Finance & Investment, released in partnership with FTI Consulting.
- Adult-Use
Looking back on the cannabis industry in 2021
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
- CBD Market
CBD-based smoking cessation formula close to patent approval
Kanabo has moved one step closer to patent approval and called for the UK to set up CBD inhalation regulation.
- Your #1 Podcast on Cannabis News
Bridging legal markets with a premium cannabis platform
On this episode of BofC Live, we connect with Oren Shuster, the CEO of IM Cannabis – a cannabis operator with footprints in Israel, Canada and Germany.
- Medical
Portfolio of doseable cannabis products launched in the UK
The products will allow patients to administer metered doses of their medicines.
- CBD Market
Europe’s Decision to Raise Permitted THC Levels in Hemp Crops Is ‘A Victory For Science’
The recent increase in hemp crop THC levels represents not only a win for the European hemp sector, but also a step forward in the direction of more science-based policies, says Lorenza Romanese.
- CBD Market
2022 plans for HEXO, California and UK CBD
HEXO reports $116.9-million loss, launches new Path Forward plan Quebec-based HEXO reported a $116.9 million loss in its first quarter and announced a new strategic plan called A Path Forward, reports Yahoo Finance.
